Real-World Use of Insulin Glargine u100 and u300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: Dosinglar Study
media
posted on 2021-05-24, 17:44 authored by Natalia Duque, Esther Artime, Irene Romera, Jeremie Lebrec, Silvia Díaz, Miriam Rubio, Antoni Sicras-Mainar, Enrique Carretero-Anibarro, Xavier Mundet, Juan J. Gorgojo-Martínez, Jesús Reviriego<p><strong>Article full
text</strong></p>
<p> </p>
<p><br></p>
<p> </p>
<p>The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021.</p>
History
Related Materials
- 1.
- 2.
